Literature DB >> 71354

Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis.

F Pass, M Reissig, K V Shah, M Eisinger, G Orth.   

Abstract

Virions isolated from warts of 2 siblings with epidermodysplasia verruciformis (EV), a rare disease characterized by the lifelong growth of warty skin tumors containing papova-like virions, were compared to isolates of human papillomavirus (HPV) from 3 pools of plantar and common hand warts. The length of relaxed, circular (form II) molecules of EV virion DNA approximated the length of HPV DNA but was 3.3% longer. Antisera prepared in rabbits against the 3 HPV pools coated and aggregated HPV in immune electron microscopy (IEM) tests but did not react with EV virions. These antisera reacted at high titers in complement fixation (CF) tests with HPV and reacted only weakly in CF tests with EV virions. Rabbit antisera to EV virions coated and aggregated EV virions but reacted only weakly or not at all with HPV virions in IEM tests. These sera reacted in CF with EV virions only. The data indicated that virions from the EV patients represent an immunologically distinct papillomavirus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71354     DOI: 10.1093/jnci/59.4.1107

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Favre; O Croissant; M Jarzabek-Chorzelska; G Rzesa
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.

Authors:  Markus Schmitt; Maurits N C de Koning; Just A H Eekhof; Wim G V Quint; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

Review 4.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

5.  Keratin polypeptide modifications induced by human papilloma viruses (HPV).

Authors:  M J Staquet; J Viac; J Thivolet
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Authors:  Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

Review 7.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

8.  The association of viruses with urveal melanoma.

Authors:  D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1979

9.  Two anatomoclinical types of warts with plantar localization: specific cytopathogenic effects of papillomavirus. Type I (HPV-1) and type 2 (HPV-2).

Authors:  R Laurent; J L Kienzler; O Croissant; G Orth
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.

Authors:  S A Jenison; J M Firzlaff; A Langenberg; D A Galloway
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.